IMRX Shares Outstanding History Table | ||||||||||||||||||||||
Also see: IMRX Market Cap History IMRX YTD Return |
IMRX Shares Outstanding History Table | ||||||||||||||||||||||
Also see: IMRX Market Cap History IMRX YTD Return |
IMRX Shares Outstanding History Chart | |||||||||||||||||||||||
+5.03% CAGR Mouse over chart for data details
|
IMRX Stock Price Chart |
About Immuneering Corp |
Immuneering is focused on improving patient outcomes by improving a pipeline of oncology and neuroscience product candidates developed using Co.'s translational bioinformatics platform. Co.'s development programs in oncology is focused on providing treatments for patients with solid tumors caused by mutations of the MAPK pathway and mTOR pathways. Co.'s primary product candidate, IMM-1-104, is designed to be a selective dual-mitogen-activated protein kinase kinase inhibitor that further disrupts kinase suppressor of RAS 1 and 2 to modulate the signaling dynamics of the MAPK pathway. In addition to IMM-1-104, Co. has six other oncology programs in the discovery stage. We show 10 historical shares outstanding datapoints in our coverage of IMRX's shares outstanding history. Understanding the changing numbers of IMRX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like IMRX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching IMRX by allowing them to research IMRX shares outstanding history as well as any other stock in our coverage universe. |
IMRX Current Stock Quote |
Free IMRX Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: Shares Outstanding Importance | |
|
IMRX Share Performance |
Shares Outstanding Peers |
Immuneering (IMRX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
IMUX Shares Outstanding History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.